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Abstract
Objective-A new variant of Gerstmann-
Straussler-Scheinker disease (GSS) was
reported, which had a substitution of glu-
tamate to lysine at codon 219 (E219K) in
addition to a P102L mutation on the same
allele of the PrP gene. However, clinical
features were not detailed and pathologi-
cal studies were not done. Unusual clini-
cal, neuroradiological, and pathological
findings are reported for these patients.
Methods and results-Clinical presenta-
tions of the patients in the same family
were variable; progressive dementia with
minimal ataxia in some patients but
ataxia without dementia in others. PET
studies with '8F-2-fluoro-2-deoxyglucose
(FDG) disclosed a relative decrease of
FDG uptake in bilateral temporoparietal
cortices of a patient with dementia, but in
the cerebellar cortices in a patient with
ataxia. At necropsy, a patient with
dementia had multicentric and diffuse
plaques stained with PrP antiserum, but
not with haematoxylin and eosin or
Congo red, in the cerebral and cerebellar
cortices.
Conclusion-Neurological and neuro-
pathological features in the patients were
atypical of the classic form of GSS with
P102L mutation. The absence of Congo
red staining prion protein plaques is
probably attributable to E219K polymor-
phism on the same allele of the PrP gene.
(J Neurol Neurosurg Psychiatry 1997;62:454-457)
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Gerstmann-Straussler-Scheinker disease (GSS)'
is a genetic form of prion disease, with clinical
features characterised by progressive ataxia
(ataxic form) or dementia (telencephalic or
dementing form). Since Hsiao et al2 first
reported the linkage of human prion protein
(PrP) mutation to the development of GSS in
1989, many point mutations in the PrP gene
have been found in patients with GSS, includ-
ing a proline to leucine substitution at codon
102 (P102L), proline to leucine at codon 105
(P105L), alanine to valine at codon 117
(A117V), tyrosine to TAG at codon 145
(Y145Stop), phenylalanine to serine at codon
198 (F198S), and glutamate to arginine at
codon 217 (Q217R).-8
The clinicopathological features (pheno-
types) of GSS vary according to the type of
PrP gene mutation. The most common PrP
gene mutation is P102L, which was also found
in the original GSS family.9 Although mental
deterioration may occur later in the course,
the predominant feature linked to the P102L
mutation is progressive ataxia of a cerebellar
type, labelled as ataxic GSS.'0 Histo-
pathologically, diffuse gliosis with neuronal
loss and many plaques occurs throughout the
brain,11 which can be shown with haema-
toxylin and eosin staining. There have been no
reports using PET of cerebral metabolic
changes in patients with GSS.
We found a Japanese family with a new vari-
ant of GSS, in which the P102L mutation is
accompanied by glutamate to lysine polymor-
phism at codon 219 (E219K) in the same
allele. We recently reported results of the gene
analysis in this family.'2 Their phenotypes
were not uniform; some of the family members
presented with the ataxic form, but the others
were characterised by progressive dementia. In
this report, we describe detailed clinical, PET,
and neuropathological features of patients
with this atypical form of GSS.
Report of cases
PATIENT 1 (PROPOSITUS; III-2)
The propositus was a 34 year old right handed
man, who was admitted to our hospital in May
1993 because of progressive mental deteriora-
tion. He was physically healthy without any
prior illness and worked as a high school
teacher until three years before the admission.
In 1990, he began to have progressive difficul-
ties in speaking and writing, and his gait
became unsteady. He was diagnosed as having
mild spinocerebellar degeneration (SCD) by a
physician in another clinic. During the next
few years, his language and cognition became
progressively disturbed. He responded only
with "yes, yes" to any questions and often lost
his way home. He lost his job at the high
school in 1993. He became dependent in his
daily living six months before admission. He
had no episodes of myoclonus, convulsions, or
hallucination.
At the time of admission, general physical
examination was normal, but his cognitive
function was severely impaired, particularly
auditory comprehension. He rarely spoke
spontaneously, and his answers to questions
consisted of short, repetitive words that were
usually unrelated to the questions. His writing
was characterised by frequent misspelling and
hypergraphia. Verbal and visual memory were
45
group.bmj.com on June 2, 2016 - Published by http://jnnp.bmj.com/Downloaded from 
A
_Japanese family with a variant of Gerstmann-Straussler-Scheinker disease
b f> ^ , 4
a PP|sav,,...r
....~~~~~
r . ,* ; '; .. ,; -/
B
(t D~~~~~~~~~~~~~~~~~t
Figure I Histological studies of cerebral and cerebellar cortices. Multicentric plaques (arrows) stained with PrP immunohistological stain in (A) the
cerebral cortex (originally magnification x 94 ) and (B) cerebellar cortex (originally x 20). (C) No neuronal loss and spongiformn changes with
haematoxylin and eosin stain in the cerebral cortex (orikinally x 43) and (D) cerebellar cortex (originally x 20). IPurkinje cells and granular layer of
cerebellum are spared.
severely impaired. He had ideomotor apraxia
with perseveration. The Wechsler adult intelli-
gence scale revised (WAIS-R) could not be
performed because of severely compromised
comprehension.
Neurological examination disclosed no nys-
tagmus and no abnormal ocular movements.
The muscle tone was diffusely increased and
muscle strength was normal. Myoclonus was
not evident. The deep tendon reflexes were
normal without Babinski's sign. He had mild
bilateral limb ataxia and a wide based gait.
Routine laboratory examinations were nor-
mal. Results of the CSF examination were all
normal. Oligoclonal IgG band and myelin
basic protein were not detected. An EEG
examination showed a background of 6-7 Hz
without asymmetry or periodic synchronous
discharges. Brain CT and MRI showed mod-
erate atrophy of the cerebral cortex but a nor-
mal cerebellum. A PET study with
intravenous injection of 18F-2-fluoro-2-deoxy-
D-glucose (FDG) showed that glucose uptake
was reduced in the temporoparietal cortices,
particularly on the right side, but was normal
and symmetric in the cerebellar cortices.
Over the next year, he progressively deterio-
rated, becoming completely disabled. In May
1994, he died of aspiration pneumonia.
Necropsy was performed seven hours after
death. The brain weighed 1290 g and was
macroscopically normal. It was fixed with
10% formalin for one month. To enhance PrP
immunoreactivity, hydrolytic autoclaving
pretreatment was used as described previ-
ously.12 For PrP antibodies, we used amyloid
plaque core (APC) antiserum and PrP-N anti-
serum. Anti-APC was prepared with amyloid
plaque core fraction from a patient with
GSS'02 and anti-PrP-N was prepared from the
synthetic peptide of N-terminal 25 amino
acids of PrP as described previously.13 The
immunostaining steps were performed with
the peroxidase-antiperoxidase method. The
histopathological findings (fig 1) were sum-
marised as follows: (1) no spongy changes and
no neuronal loss in the cerebral and cerebellar
cortices; (2) mild to moderate gliosis in the
cerebral cortices; (3) diffuse plaques in the
cerebral and cerebellar cortices, which were
not stained with haematoxylin and eosin or
Congo red, but with antihuman PrP anti-
serum; and (4) a normal spinal cord. Cerebral
PrP plaques were not recognised with PAS
staining, but cerebellar plaques were stained
weakly with PAS.
,,>,. e f
.t r s # . $ w ,
uCi° .;, 7 w
| . _7 -4 ; t &
- - 1 a t + w * /s * /: X
tt J 'i $ 9 w . ' 1, B
i, J J a&+ r, # _
; ^ . tS * t t
* $' .} S '; #
.,, X w
s JL 1+ t v
R * s , 4 , N .t N M f
f * o t t
JF. * * _ .e . e f o *
q; _, fi _* , w
; w t
z z * X ;
_ < > t, $ s v_ $ S - .
,=: } i
* t . - 4
^1 .,l
_R
455
group.bmj.com on June 2, 2016 - Published by http://jnnp.bmj.com/Downloaded from 
Tanaka, Minematsu, Mori'yasu, Yamaguchi, Yutani, Kitamoto, Furukawa
PATIENT 2 (THE FATHER OF THE PATIENT 1;
II-1)
The father of patient 1 was 64 years old and
right handed He complained of unsteadiness
in walking for the two years before evaluation.
At the time of admission for detailed neurolog-
ical evaluation in July 1993, he had dysdiado-
chokinesis of the left arm. Tandem gait was
impossible. All other neurological functions
were normal, including cognitive function.
Studies on CSF and an EEG were normal.
Brain CT disclosed a small hypodense lesion
in the left thalamus and mild brain atrophy.
There were multiple ischaemic lesions in the
thalamus, basal ganglia, and corona radiata,
but no abnormalities in the cerebellum on
MRI. An FDG-PET study showed that glu-
cose uptake was decreased predominantly in
the cerebellar cortices. Glucose uptake was
mildly decreased in the bilateral parietal cor-
tices.
FAMILY HISTORY
Among 12 family members in three genera-
tions, five had a history of progressive demen-
tia, ataxia, or both (fig 2). Patient 3 (II-4), a
56 year old, right handed woman, had a five
year history of progressive dementia. She com-
plained of unsteady walking. Patient 4 (11-7), a
44 year old, right handed man, had had slowly
progressive ataxia for 10 years. Other neuro-
logical deficits including myoclonus, spastic-
ity, and cognitive impairments were not
evident. His brain CT showed cerebellar atro-
phy. Patient 5 (I-2) reportedly had ataxic gait
and mental deterioration before death.
Detailed information about her illness could
not be obtained. Another woman (II-6) was
diagnosed as having schizophrenia at the age
of 30 years. Two years later she died of an
1 2* 3 4
2 3 4 5 6* 7
1 2 3
Codon 102 Codon 219
III-2 Case 1 (dementia) Mutation Mutation
I-2 Ataxia
II-1 Case 2 (ataxia) Mutation Mutation
II-4 Dementia Mutation Mutation
II-6 Schzophrenia?
II-7 Ataxia Mutation Mutation
III-1 Normal Normal Normal
Figure 2 Pedigree of the family. Circle = female; square = male; a black symbol =
affected with GSS; a slashed symbol = deceased; *genetic study not available.
unknown cause, and detailed information was
not available.
GENETIC STUDY
Genomic DNA was extracted from peripheral
lymphocytes of patients 1, 2, 3, and 4 and the
proband's brother (III-1) without neurological
deficits. The method of analysis was detailed
in a previous report.12 A P102L mutation of
PrP was present in all of the patients. In addi-
tion, they all had E2 19K polymorphism on the
same allele. The asymptomatic brother (III-1)
had neither the P102L nor E219K mutations.
A codon 129 showed methionine/methionine
in all cases.
Discussion
The primary clinical features of our patients
were either cerebellar ataxia without signifi-
cant cognitive impairments, or progressive
dementia with mild dystonia or ataxia. The
differential diagnosis is broad, including famil-
ial Alzheimer's disease, familial Pick's disease,
familial dementia-parkinsonism, familial dif-
fuse Lewy body disease, metachromatic
leukodystrophy, Huntington's chorea, multi-
ple sclerosis, dentorubropallidoluysian atro-
phy, and spinocerebellar degeneration. None
of these disorders, however, completely ful-
filled the clinical picture and family history of
our patients. The detection of the PrP gene
mutations established the diagnosis of GSS.
The clinicopathological pattern in our
patients with GSS was different from the classic
form of those with the P102L mutation alone.
Our patients did not always have the same
neurological picture; progressive dementia
with mild ataxia in patients 1 and 3, but ataxia
without significant cognitive impairments in
patients 2 and 4. Another family member who
may have been affected was diagnosed as hav-
ing schizophrenia, although we could not con-
firm the accuracy of the diagnosis or the
presence of PrP gene mutations. An asympto-
matic brother had a normal PrP gene.
Patient 1 had histopathological findings dif-
ferent from those typically associated with
GSS with P102L that is, numerous plaques,
visualised by haematoxylin and eosin staining.
The pathological pattern in this patient with
GSS and E2 19K polymorphism accompanied
by the P102L mutation on the same allele was
marked by cerebral cortices with diffuse
plaques which were not stained with Congo
red. However, the pathological pattern in
patients with GSS and E219K polymorphism
accompanied by the P102L mutation on the
different allele has shown Congo red staining
PrP plaques in cerebral cortices, consistent
with that of patients with GSS who had a
P1 02L mutation but not E2 19K polymor-
phism (T Kitamoto, unpublished data). These
findings indicate that codon 219 polymor-
phism of the PrP gene may modify the patho-
logical pattern in patients with the classic form
of GSS with the codon 102 mutation.
No prior studies have evaluated cerebral
metabolic changes in patients with GSS by
using PET. Studies with FDG-PET in
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patients 1 and 2 showed a variable topo-
graphic pattern of metabolic derangements,
compatible with the neurological abnormali-
ties in each patient. These results again indi-
cate that phenotypes in GSS may be
heterogenous even if patients have the same
PrP mutations.
The E219K mutation of the PrP gene that
was detected in our patients is found in 6% of
the Japanese general population without any
neurological deficits, and is considered as a
normal polymorphism. 14 Some studies have
shown that a particular PrP gene mutation or
polymorphism is accompanied by the P102L
mutation in patients with classic GSS,2 3 15 but
no study except ours'2 reported a P102L
mutation accompanied by a E219K polymor-
phism on the same allele. As the open reading
frame of the PrP gene is the same throughout
the affected members, some factors other than
this should be the cause of the atypical pheno-
type in this family. The codon 219 polymor-
phism gene may be an important factor
influencing the neurological and pathological
pattern in patients with GSS with the codon
102 mutation.
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